Dr. Balaji is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
653 North 8th street
Department of Urology, Faculty Clinic, 2nd floor
Jacksonville, FL 32209Phone+1 904-244-7340
Clinical Expertise
- Penile cancer, Biomedical research, Transitional cell carcinoma of the lower urinary tract; Lower urinary tract transitional cell carcinoma; Lower urinary tract TCC; TCC of the lower urinary tract, Cancer genetics, Urologic oncology, Erectile dysfunction, Kidney cancer, Bladder cancer, Cancer pain, Urology, Prostate cancer, Immunotherapy, Sarcomas, Laparoscopy, Robotic surgery, Drug development, Next generation sequencing, Clinical research, Chemotherapy, Medical oncology, Upper tract urothelial carcinoma, Advanced cancer, Metastatic cancer, Precision Medicine, Gene testing, Cancer research, Small molecules, Novel cancer treatment, Kinase, Inhibitor, Open urological surgery, Complex cases, PSA, Testosterone
Education & Training
UMass Chan Medical SchoolResidency, Urology, 1993 - 1997
BronxCare Health SystemInternship, Transitional Year, 1992 - 1993
Madras Medical CollegeClass of 1986
Certifications & Licensure
FL State Medical License 2018 - 2026
NC State Medical License 2010 - 2019
MA State Medical License 1995 - 2011
IL State Medical License 1999 - 2002- American Board of Urology Urology
Clinical Trials
- Ciprofloxacin Compared to Placebo in Diagnosing Prostate Cancer in Patients Undergoing Prostate Biopsy Start of enrollment: 2016 Jul 01
- International Registry for Men With Advanced Prostate Cancer (IRONMAN) Start of enrollment: 2017 Jul 21
Roles: Principal Investigator, Contact
- LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve Start of enrollment: 2021 Apr 22
Roles: Contact
Publications & Presentations
PubMed
- 10 citationsThe cytotoxic and pro-apoptotic activities of the novel fluoropyrimidine F10 towards prostate cancer cells are enhanced by Zn(2+) -chelation and inhibiting the serine ...William H. Gmeiner, Olcay Boyacioglu, Christopher H. Stuart, Jamie Jennings-Gee, K.C. Balaji
The Prostate. 2015-03-01 - 782 citationsApalutamide Treatment and Metastasis-free Survival in Prostate CancerMatthew R. Smith, Fred Saad, Simon Chowdhury, Stéphane Oudard, Boris Hadaschik
The New England Journal of Medicine. 2018-02-08 - 5 citationsNatural history, and impact of surgery and radiation on survival outcomes of men diagnosed with low-grade prostate cancer at ≤ 55 years of age: a 25-year follow-up of ...Muhammad Umar Alam, Jatinder Kumar, Daniel Norez, Jennifer Woolfe, Karthik Tanneru
International Urology and Nephrology. 2023-02-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
